Global Brain Cancer Targeted Drug Market Growth (Status and Outlook) 2023-2029

January 2023 | 62 pages | ID: GA61C677C1A0EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

A brain tumor is a mass or growth of abnormal cells in your brain. Many different types of brain tumors exist.

LPI (LP Information)' newest research report, the “Brain Cancer Targeted Drug Industry Forecast” looks at past sales and reviews total world Brain Cancer Targeted Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Brain Cancer Targeted Drug sales for 2023 through 2029. With Brain Cancer Targeted Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Brain Cancer Targeted Drug industry.

This Insight Report provides a comprehensive analysis of the global Brain Cancer Targeted Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Brain Cancer Targeted Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Brain Cancer Targeted Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Brain Cancer Targeted Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Brain Cancer Targeted Drug.

The global Brain Cancer Targeted Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Brain Cancer Targeted Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Brain Cancer Targeted Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Brain Cancer Targeted Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Brain Cancer Targeted Drug players cover Merck & Co., Roche and Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Brain Cancer Targeted Drug market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Belzutifan (Welireg)
• Bevacizumab (Avastin)
• Everolimus (Afinitor)

Segmentation by application

• Hospital
• Retail Pharmacy
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck & Co.
• Roche
• Novartis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Brain Cancer Targeted Drug Market Size 2018-2029
  2.1.2 Brain Cancer Targeted Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Brain Cancer Targeted Drug Segment by Type
  2.2.1 Belzutifan (Welireg)
  2.2.2 Bevacizumab (Avastin)
  2.2.3 Everolimus (Afinitor)
2.3 Brain Cancer Targeted Drug Market Size by Type
  2.3.1 Brain Cancer Targeted Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
2.4 Brain Cancer Targeted Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Retail Pharmacy
  2.4.3 Other
2.5 Brain Cancer Targeted Drug Market Size by Application
  2.5.1 Brain Cancer Targeted Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Brain Cancer Targeted Drug Market Size Market Share by Application (2018-2023)

3 BRAIN CANCER TARGETED DRUG MARKET SIZE BY PLAYER

3.1 Brain Cancer Targeted Drug Market Size Market Share by Players
  3.1.1 Global Brain Cancer Targeted Drug Revenue by Players (2018-2023)
  3.1.2 Global Brain Cancer Targeted Drug Revenue Market Share by Players (2018-2023)
3.2 Global Brain Cancer Targeted Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BRAIN CANCER TARGETED DRUG BY REGIONS

4.1 Brain Cancer Targeted Drug Market Size by Regions (2018-2023)
4.2 Americas Brain Cancer Targeted Drug Market Size Growth (2018-2023)
4.3 APAC Brain Cancer Targeted Drug Market Size Growth (2018-2023)
4.4 Europe Brain Cancer Targeted Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Brain Cancer Targeted Drug Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Brain Cancer Targeted Drug Market Size by Country (2018-2023)
5.2 Americas Brain Cancer Targeted Drug Market Size by Type (2018-2023)
5.3 Americas Brain Cancer Targeted Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Brain Cancer Targeted Drug Market Size by Region (2018-2023)
6.2 APAC Brain Cancer Targeted Drug Market Size by Type (2018-2023)
6.3 APAC Brain Cancer Targeted Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Brain Cancer Targeted Drug by Country (2018-2023)
7.2 Europe Brain Cancer Targeted Drug Market Size by Type (2018-2023)
7.3 Europe Brain Cancer Targeted Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Brain Cancer Targeted Drug by Region (2018-2023)
8.2 Middle East & Africa Brain Cancer Targeted Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Brain Cancer Targeted Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BRAIN CANCER TARGETED DRUG MARKET FORECAST

10.1 Global Brain Cancer Targeted Drug Forecast by Regions (2024-2029)
  10.1.1 Global Brain Cancer Targeted Drug Forecast by Regions (2024-2029)
  10.1.2 Americas Brain Cancer Targeted Drug Forecast
  10.1.3 APAC Brain Cancer Targeted Drug Forecast
  10.1.4 Europe Brain Cancer Targeted Drug Forecast
  10.1.5 Middle East & Africa Brain Cancer Targeted Drug Forecast
10.2 Americas Brain Cancer Targeted Drug Forecast by Country (2024-2029)
  10.2.1 United States Brain Cancer Targeted Drug Market Forecast
  10.2.2 Canada Brain Cancer Targeted Drug Market Forecast
  10.2.3 Mexico Brain Cancer Targeted Drug Market Forecast
  10.2.4 Brazil Brain Cancer Targeted Drug Market Forecast
10.3 APAC Brain Cancer Targeted Drug Forecast by Region (2024-2029)
  10.3.1 China Brain Cancer Targeted Drug Market Forecast
  10.3.2 Japan Brain Cancer Targeted Drug Market Forecast
  10.3.3 Korea Brain Cancer Targeted Drug Market Forecast
  10.3.4 Southeast Asia Brain Cancer Targeted Drug Market Forecast
  10.3.5 India Brain Cancer Targeted Drug Market Forecast
  10.3.6 Australia Brain Cancer Targeted Drug Market Forecast
10.4 Europe Brain Cancer Targeted Drug Forecast by Country (2024-2029)
  10.4.1 Germany Brain Cancer Targeted Drug Market Forecast
  10.4.2 France Brain Cancer Targeted Drug Market Forecast
  10.4.3 UK Brain Cancer Targeted Drug Market Forecast
  10.4.4 Italy Brain Cancer Targeted Drug Market Forecast
  10.4.5 Russia Brain Cancer Targeted Drug Market Forecast
10.5 Middle East & Africa Brain Cancer Targeted Drug Forecast by Region (2024-2029)
  10.5.1 Egypt Brain Cancer Targeted Drug Market Forecast
  10.5.2 South Africa Brain Cancer Targeted Drug Market Forecast
  10.5.3 Israel Brain Cancer Targeted Drug Market Forecast
  10.5.4 Turkey Brain Cancer Targeted Drug Market Forecast
  10.5.5 GCC Countries Brain Cancer Targeted Drug Market Forecast
10.6 Global Brain Cancer Targeted Drug Forecast by Type (2024-2029)
10.7 Global Brain Cancer Targeted Drug Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Merck & Co.
  11.1.1 Merck & Co. Company Information
  11.1.2 Merck & Co. Brain Cancer Targeted Drug Product Offered
  11.1.3 Merck & Co. Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Merck & Co. Main Business Overview
  11.1.5 Merck & Co. Latest Developments
11.2 Roche
  11.2.1 Roche Company Information
  11.2.2 Roche Brain Cancer Targeted Drug Product Offered
  11.2.3 Roche Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Roche Main Business Overview
  11.2.5 Roche Latest Developments
11.3 Novartis
  11.3.1 Novartis Company Information
  11.3.2 Novartis Brain Cancer Targeted Drug Product Offered
  11.3.3 Novartis Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Novartis Main Business Overview
  11.3.5 Novartis Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Brain Cancer Targeted Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Belzutifan (Welireg)
Table 3. Major Players of Bevacizumab (Avastin)
Table 4. Major Players of Everolimus (Afinitor)
Table 5. Brain Cancer Targeted Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Brain Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 8. Brain Cancer Targeted Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Brain Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Brain Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 11. Global Brain Cancer Targeted Drug Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Brain Cancer Targeted Drug Revenue Market Share by Player (2018-2023)
Table 13. Brain Cancer Targeted Drug Key Players Head office and Products Offered
Table 14. Brain Cancer Targeted Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Brain Cancer Targeted Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Brain Cancer Targeted Drug Market Size Market Share by Regions (2018-2023)
Table 19. Global Brain Cancer Targeted Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Brain Cancer Targeted Drug Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Brain Cancer Targeted Drug Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Brain Cancer Targeted Drug Market Size Market Share by Country (2018-2023)
Table 23. Americas Brain Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 25. Americas Brain Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Brain Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 27. APAC Brain Cancer Targeted Drug Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Brain Cancer Targeted Drug Market Size Market Share by Region (2018-2023)
Table 29. APAC Brain Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 31. APAC Brain Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Brain Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 33. Europe Brain Cancer Targeted Drug Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Brain Cancer Targeted Drug Market Size Market Share by Country (2018-2023)
Table 35. Europe Brain Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 37. Europe Brain Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Brain Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Brain Cancer Targeted Drug Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Brain Cancer Targeted Drug Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Brain Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Brain Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Brain Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Brain Cancer Targeted Drug
Table 46. Key Market Challenges & Risks of Brain Cancer Targeted Drug
Table 47. Key Industry Trends of Brain Cancer Targeted Drug
Table 48. Global Brain Cancer Targeted Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Brain Cancer Targeted Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Brain Cancer Targeted Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Brain Cancer Targeted Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Merck & Co. Details, Company Type, Brain Cancer Targeted Drug Area Served and Its Competitors
Table 53. Merck & Co. Brain Cancer Targeted Drug Product Offered
Table 54. Merck & Co. Brain Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Merck & Co. Main Business
Table 56. Merck & Co. Latest Developments
Table 57. Roche Details, Company Type, Brain Cancer Targeted Drug Area Served and Its Competitors
Table 58. Roche Brain Cancer Targeted Drug Product Offered
Table 59. Roche Main Business
Table 60. Roche Brain Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Roche Latest Developments
Table 62. Novartis Details, Company Type, Brain Cancer Targeted Drug Area Served and Its Competitors
Table 63. Novartis Brain Cancer Targeted Drug Product Offered
Table 64. Novartis Main Business
Table 65. Novartis Brain Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Novartis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Brain Cancer Targeted Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Brain Cancer Targeted Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Brain Cancer Targeted Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Brain Cancer Targeted Drug Sales Market Share by Country/Region (2022)
Figure 8. Brain Cancer Targeted Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Brain Cancer Targeted Drug Market Size Market Share by Type in 2022
Figure 10. Brain Cancer Targeted Drug in Hospital
Figure 11. Global Brain Cancer Targeted Drug Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Brain Cancer Targeted Drug in Retail Pharmacy
Figure 13. Global Brain Cancer Targeted Drug Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Brain Cancer Targeted Drug in Other
Figure 15. Global Brain Cancer Targeted Drug Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Brain Cancer Targeted Drug Market Size Market Share by Application in 2022
Figure 17. Global Brain Cancer Targeted Drug Revenue Market Share by Player in 2022
Figure 18. Global Brain Cancer Targeted Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Brain Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Brain Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Brain Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Brain Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Brain Cancer Targeted Drug Value Market Share by Country in 2022
Figure 24. United States Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Brain Cancer Targeted Drug Market Size Market Share by Region in 2022
Figure 29. APAC Brain Cancer Targeted Drug Market Size Market Share by Type in 2022
Figure 30. APAC Brain Cancer Targeted Drug Market Size Market Share by Application in 2022
Figure 31. China Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Brain Cancer Targeted Drug Market Size Market Share by Country in 2022
Figure 38. Europe Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Brain Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Brain Cancer Targeted Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Brain Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Brain Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Brain Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Brain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Brain Cancer Targeted Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Brain Cancer Targeted Drug Market Size Market Share Forecast by Application (2024-2029)